The Effects of Disease Activity and Interferon-beta on Telomere Length and Telomerase Activity in Multiple Sclerosis

被引：0
|
作者：
Wakerley, Benjamin R.
Nicholas, Richard S.
Malik, Omar R.
Altmann, Daniel M.
机构：
来源：
NEUROLOGY | 2011年 / 76卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：A135 / A135
页数：1
相关论文
共 50 条
  • [31] Aging in Fabry Disease: Role of Telomere Length, Telomerase Activity, and Kidney Disease
    Vujkovac, Andreja Cokan
    Novakovic, Srdjan
    Vujkovac, Bojan
    Stevanec, Milan
    Skerl, Petra
    Sabovic, Miso
    NEPHRON, 2020, 144 (01) : 5 - 13
  • [32] Antibodies to interferon-beta in patients with multiple sclerosis: Detection and clinical effects
    Sadiq, SA
    Revesz, KJ
    Lassman, AB
    Miller, JR
    NEUROLOGY, 1996, 46 (02) : 1073 - 1073
  • [33] The measurement of antibodies binding to interferon-beta in Iranian multiple sclerosis patients treated with interferon-beta
    Jangouk, P
    Hooshmand, E
    Vaezeafshar, R
    Lotfi, J
    Amirzargar, A
    Nikbin, B
    JOURNAL OF NEUROLOGY, 2004, 251 : 64 - 64
  • [34] Effects of Social Stress on Telomere Length and Telomerase Activity in Astatotilapia burtoni
    Guo, Y.
    Shampay, Y.
    Renn, S. C. P.
    INTEGRATIVE AND COMPARATIVE BIOLOGY, 2020, 60 : E333 - E333
  • [35] Effects of axotomy on telomere length, telomerase activity, and protein in activated microglia
    Flanary, BE
    Streit, WJ
    JOURNAL OF NEUROSCIENCE RESEARCH, 2005, 82 (02) : 160 - 171
  • [36] Serum levels of soluble CD14 correlate with disease activity in multiple sclerosis patients and are increased by interferon-beta treatment
    Lutterotti, A.
    Kuenz, B.
    Khalil, M.
    Gredler, V.
    Ehling, R.
    Gneiss, C.
    Deisenhammer, F.
    Berger, T.
    Reindl, M.
    MULTIPLE SCLEROSIS, 2006, 12 : S66 - S66
  • [37] Targets for the therapeutic action of interferon-beta in multiple sclerosis
    Hartung, HP
    Kieseier, BC
    ANNALS OF NEUROLOGY, 1996, 40 (06) : 825 - 826
  • [38] FDA OKAYS INTERFERON-BETA FOR MULTIPLE-SCLEROSIS
    THAYER, A
    CHEMICAL & ENGINEERING NEWS, 1993, 71 (31) : 5 - 6
  • [39] Interview with Ralf Gold on multiple sclerosis and interferon-beta
    Gold, R
    NERVENHEILKUNDE, 2003, 22 (11) : A1 - A2
  • [40] Depression in interferon-beta treated multiple sclerosis patients
    Guedes, R.
    Peixoto de Sousa, C.
    Curral, R.
    Silveira, C.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2019, 29 : S466 - S467
12345